What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Genetics, Haplotype, Single-nucleotide polymorphism, Genome-wide association study and Linkage disequilibrium.
Her study in Genetics is interdisciplinary in nature, drawing from both Amyotrophic lateral sclerosis, Charged multivesicular body protein 2B and TARDBP.
Her Charged multivesicular body protein 2B research is multidisciplinary, relying on both C9orf72 Protein, DNA Repeat Expansion, C9orf72 and Trinucleotide repeat expansion.
Sonja W. Scholz interconnects Exome sequencing and UBQLN2 in the investigation of issues within TARDBP.
Her research integrates issues of Genetic variability and Disease, Parkinson's disease in her study of Single-nucleotide polymorphism.
Her work investigates the relationship between Genetic variation and topics such as Allele frequency that intersect with problems in LRRK2 and Genetic heterogeneity.
Her most cited work include:
- A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2859 citations)
- A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2859 citations)
- A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2859 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Genetics, Disease, Genome-wide association study, Parkinson's disease and Single-nucleotide polymorphism.
Her study in Amyotrophic lateral sclerosis extends to Genetics with its themes.
The concepts of her Disease study are interwoven with issues in Gene, Cohort and Genetic architecture.
Sonja W. Scholz interconnects Genetic variability, Dementia with Lewy bodies, Genetic association, Age of onset and Heritability in the investigation of issues within Genome-wide association study.
Her work carried out in the field of Single-nucleotide polymorphism brings together such families of science as Odds ratio and Bioinformatics.
Her Haplotype research includes themes of Charged multivesicular body protein 2B, TARDBP and C9orf72 Protein, DNA Repeat Expansion, Trinucleotide repeat expansion.
She most often published in these fields:
- Genetics (77.93%)
- Disease (53.10%)
- Genome-wide association study (37.93%)
What were the highlights of her more recent work (between 2019-2021)?
- Disease (53.10%)
- Parkinson's disease (28.97%)
- LRRK2 (21.38%)
In recent papers she was focusing on the following fields of study:
Sonja W. Scholz mainly focuses on Disease, Parkinson's disease, LRRK2, Bioinformatics and Progressive supranuclear palsy.
Her research in Disease intersects with topics in Computational biology, Gene, Cohort study and Cohort.
Her Cohort study research is multidisciplinary, incorporating perspectives in Amyotrophic lateral sclerosis, Genotyping, Case-control study and TARDBP.
Her work in Cohort covers topics such as Single-nucleotide polymorphism which are related to areas like Oncology.
Her Bioinformatics research incorporates elements of Genetic risk, Proteostasis, Locus, Regulation of gene expression and Tauopathy.
Her Dementia research is multidisciplinary, relying on both Genetics, Alpha-synuclein, Glucocerebrosidase, Huntingtin and Etiology.
Between 2019 and 2021, her most popular works were:
- Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia (39 citations)
- Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia (39 citations)
- Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. (23 citations)
In her most recent research, the most cited papers focused on:
Sonja W. Scholz mostly deals with Disease, LRRK2, Parkinson's disease, Genome-wide association study and Lewy body.
Her Disease study integrates concerns from other disciplines, such as RNA, Viral infection and Virology.
Her LRRK2 research incorporates themes from Heterozygote advantage, Mutation, Confidence interval, Penetrance and Risk factor.
Her study in Parkinson's disease is interdisciplinary in nature, drawing from both Odds ratio and Oncology.
Her studies deal with areas such as Progressive supranuclear palsy, Expression quantitative trait loci, Proportional hazards model, Hazard ratio and Cohort as well as Genome-wide association study.
Sonja W. Scholz has included themes like Glucocerebrosidase, Genetics, Alpha-synuclein and Age of onset in her Lewy body study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
